Confidentiality agreements
Open discussions are key to any successful collaboration. To protect the rights of each partner, it is strongly advised to sign a confidentiality agreement before the discussions start. Then information can be exchanged freely to determine whether a formal collaboration is indeed possible and useful. If this is the case, the next step is to draw up a collaboration agreement.
Confidentiality agreements are also referred to as non-disclosure agreements (NDA) or confidential disclosure agreements (CDA).
Standardized templates for Vrije Universiteit Amsterdam and VU University Medical Center can be found below.
These templates have been approved by IXA. If changes to the contents of the agreements are needed, IXA needs to be involved, otherwise just fill in the required fields and have the agreement signed by your department/faculty manager.
Confidentiality agreements
If you have questions regarding these templates, please contact:
VU professor Davide Iannuzzi wins NWO Physics Valorisation Prize 2018
The tenth NWO Physics Valorisation Prize will go to Prof. Davide Iannuzzi, professor of Experimental Physics at Vrije Universiteit Amsterdam (VU). He has won the prize “on account of the valorisation of this own research and the attention he gives to facilitating valorisation by others”. The award ceremony will take place on 22 January 2019 […]
News
NWO-Demonstrator Grant for methane leak detection
Imran Avci and Davide Iannuzzi (Vrije Univeriteit Amsterdam) have been awarded an NWO-Demonstrator Grant. The grant will give them the opportunity to test whether their PAS-WRAP technology can be used to detect methane leaks in oil and gas extraction facilities. The project is based on a new approach to gas trace detection that offers high […]
News
Azafaros secures seed investment from BioGeneration Ventures
Azafaros, a biotech company established in Leiden in the Netherlands, focusing on the development of new therapies in the field of rare metabolic disorders, announced the closing of a seed financing round. BioGeneration Ventures (BGV) is the founding investor. Rare metabolic disorders such as lysosomal storage disorders (LSDs) represent a broad class of severe and […]
News